Liraglutide
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
Novo Nordisk · Phase 3 · Status n/r · Enrollment 60
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Benaglutide | n/r | n/r | n/r | n/r |
| Liraglutide | n/r | n/r | n/r | n/r |
Not shown
- Benaglutide: endpoint not reported
- Liraglutide: endpoint not reported